A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation E in Healthy Adults

Project: Research project

Project Details

StatusActive
Effective start/end date10/6/2510/5/27

Funding

  • Merck Sharp and Cohme Corporation ( Award # ): $13,000.00